Beta-blockade in acute myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001262:Atenolol / Q000009:adverse effects / Q000627:therapeutic use; D001919:Bradycardia / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000378:metabolism; D004562:Electrocardiography; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007527:Isoenzymes; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D007527:Isoenzymes; D001262:Atenolol; D003402:Creatine Kinase